Fondaparinux NA Injection
Marketer
Lupin Ltd
Salt Composition
Fondaparinux (NA)
Overview Fondaparinux NA Injection
Fondaparinux NA Injection is an anticoagulant medication employed to treat deep vein thrombosis (leg vein clots) and pulmonary embolism (lung artery clots). Its action prevents the formation of potentially dangerous blood clots within blood vessels. This injection also mitigates clot risk in patients recovering from hip or knee replacement surgery, or those experiencing prolonged immobility. Administration is strictly under medical supervision; dosage and treatment length are determined individually by your physician. Continued use of all other prescribed medications should be maintained throughout your treatment. Increased bleeding risk is a potential side effect; report any unusual bleeding (e.g., petechiae, hematuria, or melena) to your doctor immediately. Prior to commencing treatment, disclose any bleeding disorders, hepatic or renal impairments, pregnancy, breastfeeding, or other concurrent medications to your physician.
Primary Ingredients of Fondaparinux NA Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Fondaparinux NA Injection
Blood clots in deep veins and lungs
Major Benefits of Fondaparinux NA Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Fondaparinux NA Injection:
- Bleeding
- Anemia (low number of red blood cells)
How to use Fondaparinux NA Injection:
Administering this medication will be handled by your physician or their registered nurse; patient self-administration is strictly prohibited.
How Fondaparinux NA Injection works:
Fondaparinux sodium injection acts as a blood thinner, inhibiting the activity of factor Xa, a clotting agent in the bloodstream. This action prevents the development of undesirable blood clots within the circulatory system.
SAFETY ADVICE
AlcoholUNSAFE
Combining Fondaparinux NA Injection and alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Fondaparinux NA Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; however, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers may likely use Fondaparinux NA Injection without significant safety concerns. Available data from humans indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
Fondaparinux NA Injection's effect on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Individuals with kidney impairment should use Fondaparinux NA Injection cautiously, as dose modification may be necessary. Severe kidney disease contraindicates the use of Fondaparinux NA Injection; physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Fondaparinux NA Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Fondaparinux NA Injection :
Should you forget a dose of Fondaparinux NA Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Fondaparinux NA Injection
| Label | Value |
|---|---|
| Chemical Category | Glucopyranoside analog |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | Activated Factor X-selective inhibitor |
3,018 People bought this recently